Abstract
Acute exposure to toxic or poisonous substances can be intentional or accidental. The onset of the toxic effect depends on the degree of absorption of the toxicant. The management of acute exposure to toxicants is generally supportive. Knowledge of the pharmacokinetics and pharmacodynamics of the offending agent is important. The use of pharmacological agents in treating poisoning is to manipulate the pharmacokinetic or pharmacodynamic profiles of the toxicant. These pharmacological agents will minimize the absorption and/or enhance the elimination of the toxicant from the body. Specific antidotes are used to alter the effects of certain known toxicants through neutralization and pharmacological antagonism. Having the ability to identify the effect of specific classes of substances on the body (toxidromes) will facilitate the selection of an appropriate management strategy to optimize the outcome.
Access provided by Autonomous University of Puebla. Download chapter PDF
Similar content being viewed by others
Keywords
Introduction
Medical toxicology is one of the four subspecialties of toxicology. It deals with human exposure to toxic substances. The origin of these toxic substances can be from animal, plant or synthetic materials. Human exposure to these toxoids and toxins can either be intentional (deliberate), unintentional (accidental) or fabricated (induced). Many toxins and toxoids have long been utilized as pesticides, herbicides, fertilizers, household cleaners, cosmetics, pharmaceutical and other useful products of daily use. Unfortunately, some of these substances have been used for intentional poisoning (of individuals, targeted groups of people or the general public), biological warfare and antipersonnel terrorism.
General Principles
The effects of poisoning or envenoming begin with the exposure to large enough amounts of xenobiotics (foreign, natural or man-made substances) to cause harm or damage to the body. These toxic substances enter the body through various routes such as oral (most common), intradermal, intravascular or inhalational. The rate of absorption predicts the onset of action, while the extent of absorption reflects the bioavailability and its pharmacological effect. Absorption rate, bioavailability and elimination of these toxicants are influenced by physical factors (molecular weight, blood flow, surface area, contact time) and chemical factors (water/lipid solubility, polarity, pH of the medium). The general approach to toxic exposures is to remove the patient from the substance and the substance from the patient as soon as and as completely as possible.
Approaches to Acute Poisoning
This involves various methods and pharmacological manipulation to alter the pharmacokinetics and pharmacodynamics of toxicants. Treatment should take place in tandem with but not be delayed by diagnostic, screening or laboratory investigations.
-
1.
Preventing further gastrointestinal (GI) absorption (Gastric decontamination)
-
(a)
Emesis: Syrup ipecac (active compounds: emetine and cephaeline) act locally by irritating the gastric mucosa and centrally by stimulating the medullary chemoreceptor trigger zone to induce vomiting to reduce the poison load. Ipecac is only considered immediately post toxic ingestion due to the significant risk of aspiration especially in those with decreased level of consciousness.
-
(b)
Activated charcoal: This is the most frequently used agent for GI decontamination. The high degree of microporosity (>500 m2 per g) of activated charcoal makes it an excellent adsorbing agent, binding to a wide selection of drugs and their metabolites. When administered early following toxic ingestion, it significantly reduces gastrointestinal absorption, enterohepatic circulation and enteroenteric circulation.
-
(c)
Cathartic: Cathartics enhance bowel transit. The indication is similar to activated charcoal and is often used with activated charcoal. Magnesium citrate, magnesium sulfate and sorbitol can decrease intestinal transit time and absorption of the ingested xenobiotics. Severe diarrhea is a major adverse effect and requires careful monitoring of the hydration status. Magnesium salt-containing cathartics should be avoided in patients with renal failure, due to risk of magnesium toxicity.
-
(d)
Gastrointestinal irrigation: Orogastric lavage with small amounts of warm fluid through an appropriately placed orogastric tube is only considered in alert patients presenting within 60 min of life threatening toxic ingestions. This procedure is limited to the irrigation of preparations small enough to pass through the orogastric tube, and substances that cause delay in gastric emptying, gastric outlet obstruction or concretion. Whole bowel irrigation using non-absorbable polyethylene glycol has a role in the toxic ingestion of petroleum products, iron, lithium, sustained-release-enteric-coated formulations or in patients who are “body packers” i.e. transporting illicit drugs in their bowel.
-
(a)
-
2.
Increasing elimination (by manipulating urine pH, or by extracorporeal techniques)
-
(a)
Alkalinization of urine – weak acids like salicylates and barbiturates, ionize in alkaline urine resulting in an increase in their renal excretion (Fig. 27.1). Sodium bicarbonate is administered as IV bolus or infusion to maintain the urinary pH between 7.5 and 8.5. Continuous infusion is adjusted to clinical response or until serum pH is maintained between 7.50 and 7.55. This procedure is contraindicated in hypokalemia, and in those with renal insufficiency (not able to tolerate volume or sodium load).
-
(b)
Acidification of urine – Basic drugs like amphetamines, quinine, ephedrine and flecainide, ionize in acidic urine and are excreted more readily. Urine acidifiers include ammonium chloride and vitamin C.
-
(c)
Non-pharmacological approaches – peritoneal dialysis or hemodialysis can increase the elimination of salicylates, lithium, barbiturates, methanol, ethylene glycol and ethanol.
-
(a)
-
3.
Use of antidote (interfering with the pharmacodynamics or toxic effects of poison)
-
(a)
Neutralization of the circulating toxicant/toxin – this can be achieved with the use of antibody e.g. DigiFab (for digoxin) and antivenom (for venom), or chelating agents such as desferrioxamine (for iron). The rationale is that the therapeutic agent binds (chemically or immunologically) to the toxic agent, rendering it inactive while enhancing its elimination (e.g. immunocomplexes will be phagocytozed).
-
(b)
Antagonizing the toxic effects – typically this can be achieved with the use of an antagonist, such as atropine (for cholinergic poisoning), and cholinesterase inhibitor (for non-depolarizing neuromuscular blocker overdose). In organophosphate poisoning that inhibits cholinesterase, pralidoxime is an antidote that reactivates the phosphorylated cholinesterase. Other examples include flumazenil and naloxone that competitively antagonize the actions of benzodiazepines and opioids, respectively (see Chap. 7).
-
(c)
Reducing the generation of toxic metabolite: This is useful for drugs which have toxic metabolites for example, acetaminophen (paracetamol). N-acetylcysteine is an antidote that restores hepatic glutathione, which detoxifies the toxic metabolite, N-acetyl-p-benzoquinone imine (NAPQI) (Fig. 27.2).
-
(a)
Key Concepts
-
Drug manipulation can alter the pharmacokinetics (reducing absorption or enhancing elimination) and pharmacodynamics (preventing or ameliorating toxic effect) of toxic substances.
-
Choosing the appropriate method of treating poisoning requires good understanding of how different toxic substances are introduced and act on the body. The dose and duration of exposure prior to receiving medical care will determine the appropriate treatment pathway.
Summary
The primary goal in the management of poisoning is to prevent or reduce further injury. In general, supportive care plays a major role in all types of poisoning. Pharmacological approaches, however, are useful to reduce the absorption and to enhance the elimination of the toxic substance. The use of appropriate antidote may prove to be a useful mode of therapy to neutralize the toxic effects of some compounds. Timely administration of appropriate treatment modalities for the acutely poisoned ensures a favorable outcome.
Further Reading
Brunton L, Blumenthal D, Buxton I, Parker K, editors. Goodman & Gilman manual of pharmacology and therapeutics. 11th ed. New York: McGraw Hill; 2008.
Harvey RA, Clark MA, Finkel R, Rey JA, Whalen K, editors. Lippincott illustrated reviews pharmacology. 5th ed. Philadelphia: Wolters Kluwer; 2012.
Hoffman RS, Howland MA, Lewin NA, Nelson LS, Goldfrank LR. Goldfrank’s toxicologic emergencies. 10th ed. New York: McGraw-Hill Professional; 2014.
Marx J, Hockberger R, Walls R. Rosen’s emergency medicine – concepts and clinical practice: expert consult premium edition. 8th ed. Philadelphia: Saunders; 2013.
Prescott LF, Balali-Mood M, Critchley JA, Johnstone AF, Proudfoot AT. Diuresis or urinary alkalinisation for salicylate poisoning? Br Med J (Clin Res Ed). 1982;285(6352):1383–6.
Rang HP, Dale MM, Ritter JM, Flower RJ, Henderson G. Rang and Dale’s pharmacology. 7th ed. Edinburgh: Churchill Livingstone; 2012.
Tintinalli JE, Stapczynski JS, Ma OJ, Cline DM, Cydulka RK, Meckler GD. Tintinalli’s emergency medicine: a comprehensive study guide. 7th ed. New York: McGraw-Hill; 2010.
Tripathi KD. Essentials of medical pharmacology. 7th ed. New Delhi: Jaypee Brothers; 2013.
White J, Meier J. Handbook of clinical toxicology of animal venoms and poisons. 1st ed. Boca Raton: CRC Press; 1995.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Tan, C.H., Ismail, A.K. (2015). The Poisoned Patient. In: Chan, Y., Ng, K., Sim, D. (eds) Pharmacological Basis of Acute Care. Springer, Cham. https://doi.org/10.1007/978-3-319-10386-0_27
Download citation
DOI: https://doi.org/10.1007/978-3-319-10386-0_27
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-10385-3
Online ISBN: 978-3-319-10386-0
eBook Packages: MedicineMedicine (R0)